Article
The FDA has approved a new tradename and revised labeling for Alcon's sterile, balanced salt solution (AquaLase Solution) for use as an isotonic solution for irrigating eye tissues.
Opthea phase 3 clinical trial, COAST, in patients with wet age-related macular degeneration fails to meet primary endpoint
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Unity Biotechnology releases topline results from phase 2b ASPIRE trial of UBX1325 in patients with diabetic macular edema
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Importance of evaluating cerebrospinal fluid at vitreoretinal lymphoma diagnosis
Bausch + Lomb publishes results from phase 4 study evaluating patient-reported outcomes with Miebo in dry eye disease